Login to Your Account

Other News To Note

Thursday, May 9, 2013

• pSivida Corp., of Watertown, Mass., said Iluvien (fluocinolone acetonide intravitreal implant) was launched in Germany in chronic diabetic macular edema by licensee Alimera Sciences Inc., of Atlanta. Earlier this month, Alimera resubmitted the new drug application for Iluvien, which has a PDUFA date of Oct. 17.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription